🇺🇸 FDA
Patent

US 12258597

Methods and compositions for therapeutic protein delivery

granted A61KA61K2039/505A61K38/47

Quick answer

US patent 12258597 (Methods and compositions for therapeutic protein delivery) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/505, A61K38/47, A61K47/6815, A61K47/6849